Your Science.
Our Manufacturing Power.
One Seamless Path.
The right Contract Development and Manufacturing Organization (CDMO) partner doesn’t just make your product—it accelerates your success. At SCTbio, we deliver expertise, flexibility, and scale for every stage of your cell and gene therapy journey. Backed by PPF Group, we combine world-class manufacturing with seamless execution.
Measured in Results.
Proven in Impact.
~20
years
manufacturing cell & gene therapies
3
Qualified Persons on Site for agile batch release
150+
legacy EU/US qualified apheresis sites — unmatched expertise in clinical collection management
2,000+
GMP batches manufactured
2,000 m²
of advanced facilities, including 420 m² of Class A/B/C GMP cleanrooms
12,000
IMPs delivered worldwide
75+
cell therapy experts dedicated to your success
End-to-End Solutions.
Built for Your Therapy.
From bench to bedside, SCTbio offers full-service support for Advanced Therapy Medicinal Products (ATMPs):
cGMP Manufacturing and Quality Control
Cell therapy and viral vector
expertise with robust in-house QC capabilities
Lentiviral & Gammaretroviral Vector Production & Testing
Viral vectors development and manufacturing - scalable RUO & GMP grades
Analytical
Development
Analytical development include
method development,
optimization, and validation
Process Development & Tech Transfer
Scalable, optimized processes
with successful transfer from lab to GMP
Apheresis Collection
& Logistics
Seamless needle‑to‑needle coordination across 150+ EU/US legacy apheresis sites — from apheresis to patient delivery
Storage
& Distribution
Proprietary global GxP logistics, controlled storage, and cold chain management
Quality & Regulatory Support & Qualified Person Services
QP batch release under EU GMP and global compliance support
What Our Partners Say About Us
“Auditing SCTbio revealed to us a company in which GMP culture is deeply rooted, the quality system is well structured, and GMP readiness is not just a marketing keyword thanks to the constant effort of SCTbio’s people, their expertise, their commitment, and their attention to quality.”
Laporte Euro
“SCTbio already had an impressive track record of experience with autologous cell therapy manufacturing, including not just GMP manufacturing and analytical capabilities, but a sophisticated cold chain operation, scheduling and supply chain software, and extensive network of qualified leukapheresis sites.”
SOTIO Biotech
“SCTbio stands out as a reliable partner for customized cryopreservation and logistic services. We were impressed by the experienced team's willingness to collaborate, helping accommodate our unique requirements with an impressive commitment to quality that ensures our leukopaks continue to meet the needs of our customers.”
Cyto-Care.eu GmbH
Extensive Global Heritage in Apheresis Management
SCTbio draws on a long-standing legacy of working with more than 150 qualified and trained cell-collection sites across Europe and the USA. We provide dedicated apheresis support, with rapid reactivation and site‑specific procedure alignment to secure high‑quality clinical starting material.
